CliffBio
small molecule

DRIZALMA SPRINKLE

DULOXETINE HYDROCHLORIDE

Loss of exclusivityApril 2037latest FDA-listed patent expiry
CompanySUN PHARMACEUTICAL INDUSTRIES LTD

Drug detail

Brand nameDRIZALMA SPRINKLE
Active ingredientDULOXETINE HYDROCHLORIDE
StrengthEQ 40MG BASE
Dosage formCAPSULE, DELAYED REL PELLETS
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2019
Marketing statusRX

Listed patents

PatentExpiresType
11202772April 2037product
9839626April 2037product
10413525April 2037product
10959982April 2037product
12171742April 2037product

More from SUN PHARMACEUTICAL INDUSTRIES LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

DRIZALMA SPRINKLE patent cliff — loss of exclusivity April 2037 | CliffBio